Literature DB >> 18828858

EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds.

.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18828858     DOI： 10.1111/j.1469-0691.2008.02086.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  157 in total

1.  Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea.

Authors:  E Alvarez; D Garcia-Hermoso; D A Sutton; J F Cano; A M Stchigel; D Hoinard; A W Fothergill; M G Rinaldi; F Dromer; J Guarro
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

2.  Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.

Authors:  Moan Shane Tsai; Yun Liang Yang; An Huei Wang; Lih Shinn Wang; Daniel C T Lu; Ci Hong Liou; Li Yun Hsieh; Chi Jung Wu; Ming Fang Cheng; Zhi Yuan Shi; Hsiu Jung Lo
Journal:  Mycopathologia       Date:  2012-02-09       Impact factor: 2.574

3.  Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species.

Authors:  Elena De Carolis; Antonietta Vella; Ada R Florio; Patrizia Posteraro; David S Perlin; Maurizio Sanguinetti; Brunella Posteraro
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

4.  Molecular epidemiology of Aspergillus fumigatus isolates harboring the TR34/L98H azole resistance mechanism.

Authors:  Simone M T Camps; Antonius J M M Rijs; Corné H W Klaassen; Jacques F Meis; Céline M O'Gorman; Paul S Dyer; Willem J G Melchers; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2012-06-06       Impact factor: 5.948

5.  Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.

Authors:  Ana Alastruey-Izquierdo; Isabel Cuesta; Grit Walther; Manuel Cuenca-Estrella; Juan Luis Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

6.  Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates.

Authors:  M Pfaller; L Boyken; R Hollis; J Kroeger; S Messer; S Tendolkar; D Diekema
Journal:  J Clin Microbiol       Date:  2011-01-05       Impact factor: 5.948

Review 7.  Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature.

Authors:  Simone M T Camps; Jan W M van der Linden; Yi Li; Ed J Kuijper; Jaap T van Dissel; Paul E Verweij; Willem J G Melchers
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

8.  Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.

Authors:  Ana Alastruey-Izquierdo; Maria Victoria Castelli; Isabel Cuesta; Araceli Monzon; Manuel Cuenca-Estrella; Juan Luis Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

9.  Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis.

Authors:  Seyedmojtaba Seyedmousavi; Willem J G Melchers; Johan W Mouton; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

10.  In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods.

Authors:  Michael A Pfaller; Shawn A Messer; Mary R Motyl; Ronald N Jones; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.